Pathways to Precision and Perfection

The Combined Symposium of the Cataract & Refractive Societies (CSCRS) explored three areas of contention during the 36^th APACRS-24^th CSCRS Joint Meeting, in its ongoing pursuit of precise and perfect surgical outcomes:

• Light Adjustable Lens (LAL) vs. IOL Formulae
• Phaco vs. Femto
• SMILE vs. LASIK

• On- and off-label indications for small aperture technology

Ophthalmologists discussed their experience using the lens, including how it can be applied for patients who previously had limited options: particularly those with irregular astigmatism.

• Floaters getting in the way of postop patient happiness

Floaters can impact patient perception and happiness with their vision after cataract surgery, but there is some division as to methods of treatment, especially as YAG laser vitreolysis becomes more common. Cataract and Retina specialists shared their views on this topic.

• Cataract surgery in patients with keratoconus

Cataract surgery for patients with keratoconus is complex, with challenges in pre-surgery planning, surgery, and post-surgical care. New technologies like keratoconus-specific IOL formulas and advanced lens technology offer hope for better outcomes. Despite these advancements, significant challenges persist in optimizing results for this unique population.

• Angle kappa and its influence on multifocal IOL outcomes

A recent study explored the influence of angle kappa on multifocal IOL outcomes. Two of the researchers shared the motivation behind this study, what was discovered, and what this means for future research.

• The impact of HOAs on refractive options and outcomes

Higher Order Aberrations (HOAs) are crucial measurements in preoperative evaluations for refractive and cataract surgeries, as they significantly influence surgical outcomes. Preoperative assessment of HOAs helps ensure optimal outcomes and avoids potential complications.

• Cataract surgery in eyes with endothelial damage

When planning cataract surgery, it’s important to pay particular attention to patients who may have a compromised cornea or endothelial damage. Two cornea specialists spoke about considerations for cataract surgery in these eyes.

• Knocking down XEN obstacles

Two surgeons shared their insights, and challenges encountered when using the XEN Gel Stent (AbbVie), which originally received FDA approval in 2016.

• Role of Artificial Intelligence in Myopia Control